Cargando…

α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population

BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subj...

Descripción completa

Detalles Bibliográficos
Autores principales: Gall, Walter E., Beebe, Kirk, Lawton, Kay A., Adam, Klaus-Peter, Mitchell, Matthew W., Nakhle, Pamela J., Ryals, John A., Milburn, Michael V., Nannipieri, Monica, Camastra, Stefania, Natali, Andrea, Ferrannini, Ele
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878333/
https://www.ncbi.nlm.nih.gov/pubmed/20526369
http://dx.doi.org/10.1371/journal.pone.0010883
_version_ 1782181855042207744
author Gall, Walter E.
Beebe, Kirk
Lawton, Kay A.
Adam, Klaus-Peter
Mitchell, Matthew W.
Nakhle, Pamela J.
Ryals, John A.
Milburn, Michael V.
Nannipieri, Monica
Camastra, Stefania
Natali, Andrea
Ferrannini, Ele
author_facet Gall, Walter E.
Beebe, Kirk
Lawton, Kay A.
Adam, Klaus-Peter
Mitchell, Matthew W.
Nakhle, Pamela J.
Ryals, John A.
Milburn, Michael V.
Nannipieri, Monica
Camastra, Stefania
Natali, Andrea
Ferrannini, Ele
author_sort Gall, Walter E.
collection PubMed
description BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. METHODS: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). RESULTS: Random forest statistical analysis selected α-hydroxybutyrate (α–HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M(FFM) = 33 [12] µmol·min(−1)·kg(FFM) (−1), median [interquartile range], n = 140) from insulin sensitive subjects (M(FFM) = 66 [23] µmol·min(−1)·kg(FFM) (−1)) with a 76% accuracy. By targeted isotope dilution assay, plasma α–HB concentrations were reciprocally related to M(FFM); and by partition analysis, an α–HB value of 5 µg/ml was found to best separate insulin resistant from insulin sensitive subjects. α–HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to α-HB metabolism and biosynthesis. CONCLUSIONS: α–hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress.
format Text
id pubmed-2878333
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-28783332010-06-04 α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population Gall, Walter E. Beebe, Kirk Lawton, Kay A. Adam, Klaus-Peter Mitchell, Matthew W. Nakhle, Pamela J. Ryals, John A. Milburn, Michael V. Nannipieri, Monica Camastra, Stefania Natali, Andrea Ferrannini, Ele PLoS One Research Article BACKGROUND: Insulin resistance is a risk factor for type 2 diabetes and cardiovascular disease progression. Current diagnostic tests, such as glycemic indicators, have limitations in the early detection of insulin resistant individuals. We searched for novel biomarkers identifying these at-risk subjects. METHODS: Using mass spectrometry, non-targeted biochemical profiling was conducted in a cohort of 399 nondiabetic subjects representing a broad spectrum of insulin sensitivity and glucose tolerance (based on the hyperinsulinemic euglycemic clamp and oral glucose tolerance testing, respectively). RESULTS: Random forest statistical analysis selected α-hydroxybutyrate (α–HB) as the top-ranked biochemical for separating insulin resistant (lower third of the clamp-derived M(FFM) = 33 [12] µmol·min(−1)·kg(FFM) (−1), median [interquartile range], n = 140) from insulin sensitive subjects (M(FFM) = 66 [23] µmol·min(−1)·kg(FFM) (−1)) with a 76% accuracy. By targeted isotope dilution assay, plasma α–HB concentrations were reciprocally related to M(FFM); and by partition analysis, an α–HB value of 5 µg/ml was found to best separate insulin resistant from insulin sensitive subjects. α–HB also separated subjects with normal glucose tolerance from those with impaired fasting glycemia or impaired glucose tolerance independently of, and in an additive fashion to, insulin resistance. These associations were also independent of sex, age and BMI. Other metabolites from this global analysis that significantly correlated to insulin sensitivity included certain organic acid, amino acid, lysophospholipid, acylcarnitine and fatty acid species. Several metabolites are intermediates related to α-HB metabolism and biosynthesis. CONCLUSIONS: α–hydroxybutyrate is an early marker for both insulin resistance and impaired glucose regulation. The underlying biochemical mechanisms may involve increased lipid oxidation and oxidative stress. Public Library of Science 2010-05-28 /pmc/articles/PMC2878333/ /pubmed/20526369 http://dx.doi.org/10.1371/journal.pone.0010883 Text en Gall et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gall, Walter E.
Beebe, Kirk
Lawton, Kay A.
Adam, Klaus-Peter
Mitchell, Matthew W.
Nakhle, Pamela J.
Ryals, John A.
Milburn, Michael V.
Nannipieri, Monica
Camastra, Stefania
Natali, Andrea
Ferrannini, Ele
α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title_full α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title_fullStr α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title_full_unstemmed α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title_short α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
title_sort α-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878333/
https://www.ncbi.nlm.nih.gov/pubmed/20526369
http://dx.doi.org/10.1371/journal.pone.0010883
work_keys_str_mv AT gallwaltere ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT beebekirk ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT lawtonkaya ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT adamklauspeter ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT mitchellmattheww ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT nakhlepamelaj ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT ryalsjohna ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT milburnmichaelv ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT nannipierimonica ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT camastrastefania ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT nataliandrea ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT ferranniniele ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation
AT ahydroxybutyrateisanearlybiomarkerofinsulinresistanceandglucoseintoleranceinanondiabeticpopulation